Abstract
Literature using electronic health record-linked data examining healthcare resource utilization (HCRU) and costs in patients with metastatic breast cancer (mBC) from the US-payer perspective is scarce. We aimed to describe demographic/clinical characteristics, HCRU, and costs for patients with mBC and a subset with the HR+/HER2+ subtype.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
